Counterfeit Medicine

©image: PhotoXpress

Nicaragua has developed into a major marketplace for counterfeit medicine manufactured without any quality controls. Its epicenter is in the capital's so-called "Eastern Market" where many popular drugs can be purchased.

Alejandra Ehlers writing for Laprensa.com.ni comments that, "the sale of fake drugs is a problem that has spread across the world. According to the World Health Organization (WHO) one in ten of all medicines sold is fake, ineffective or has the potential to cause death".

The counterfeit medicines market is controlled by powerful and violent groups associated with drug trafficking.

Source: laprensa.com.ni

More on this topic

"Dr. Simi" goes for the Guatemalan market.

August 2008

Four years after forming an alliance to take the Similares Pharmacies to Guatemala, Rigoberta Menchú Tum and Mexican, Victor Gonzalez Torres have separated.

This business story started on a spring night in Mexico. Customers were enjoying a seafood platter covered with red wine in the French restaurant at the luxurious Intercontinental Presidential Hotel.

Salvadoran Laboratory explores the generic market

February 2009

Ancalmo Laboratories have launched two new generic medications on the market, with prices of around 30% to 40% less than the brand names.

LA PRENSA GRAFICA.com reports that "Ancalmo says that one of the reason why they decided to enter this sector is because it is "a good opportunity" due to the imminent approval of the Law of Generic Medication and Access to to medication.

Latin America Intends to Harmonize Medication Controls

April 2011

Over 100 experts from Latin America and the United States, plus observers from Switzerland, the United Kingdom, Spain and Austria, participated in the III annual conference for pharmaceutical regulation in the region.

The event was organized by the Food and Drug Administration of the U.S. and sponsored by the Panamanian Health Ministry. Participants discussed drug control, registry, verification and supply chain security.

Guatemala’s “Grupo Pharma” to Invest in Mexico

May 2010

The pharmaceutical consortium will install a $25 million lab in the Mexican state of Chiapas.

The facility is expected to employ 180 workers in its first year of operation, growing to 300 over the next four years.

“Some 300 generic medicines will be elaborated in Grupo Pharma’s laboratory in Chiapas. The company also plans to open 400 drug stores in the southern states of Mexico”, reported Terra.com.